Alpha-1A, 1B, and 1D adrenergic receptors (α1A-AR, α1B-AR, α1D-AR)

The alpha-1 adrenergic receptor family (α1A, α1B, α1D) are G protein-coupled receptors primarily responsive to the endogenous catecholamines epinephrine and norepinephrine. Upon activation, they couple to the Gq protein and trigger a signaling cascade leading to phospholipase C activation, inositol trisphosphate production, calcium release, and protein kinase C activation. These receptors mediate vasoconstriction, smooth muscle contraction, regulation of cognition and neurotransmission, metabolism, and cell proliferation. Their differential tissue expression and functional roles make each subtype distinct in physiological and therapeutic contexts. Selective antagonists are widely used in the management of hypertension, benign prostatic hyperplasia, and certain cardiovascular and inflammatory diseases. Recent structural studies have enabled the rational design of subtype-selective ligands and research tools, supporting future drug development and deeper understanding of their biology.

Other names

Alpha-1A adrenoceptorAlpha-1B adrenoceptorAlpha-1D adrenoceptorα1A-AR, α1B-AR, α1D-ARalpha-1 adrenergic receptorα1-adrenergic receptor

Antagonists block receptor activation, causing relaxation of smooth muscle, dilation of blood vessels, reduction of blood pressure. Agonists stimulate receptor to induce vasoconstriction, smooth muscle contraction, increased blood pressure, and other physiological responses. Drugs may show subtype selectivity or act broadly, exhibiting differences in clinical effect and side effect profiles.